Samuel Zentman - 05 Aug 2025 Form 4 Insider Report for Klotho Neurosciences, Inc. (KLTO)

Role
Director
Signature
Samuel Zentman
Issuer symbol
KLTO
Transactions as of
05 Aug 2025
Transactions value $
$4,100
Form type
4
Filing time
08 Aug 2025, 06:00:11
Previous filing
03 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ZENTMAN SAMUEL M Director 1300 SOUTH BOULEVARD SUITE D, CHARLOTTE Samuel Zentman 07 Aug 2025 0001309349

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KLTO Common Stock Award +153K +26.33% 736K 05 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLTO Non-Qualified Stock Option Award $4.1K +10K +33.33% $0.41 40K 07 Aug 2025 Common Stock 10K $0.41 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person received the shares as contingent merger consideration.
F2 The Reporting Person is the beneficial owner of the shares which are owned by The Samuel Zentman 2012 Irrevocable Trust.
F3 Options are fully vested and can be exercised at any time.